The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Efficacy results of a phase II trial (AGMT MBC-6).
 
Gabriel Rinnerthaler
Consulting or Advisory Role - Celgene; Pierre Fabre
Speakers' Bureau - Amgen; AstraZeneca; Novartis
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Simon Peter Gampenrieder
Honoraria - Roche
Consulting or Advisory Role - Novartis; Roche
Speakers' Bureau - AstraZeneca; Novartis; Roche
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Daniela Voskova
Consulting or Advisory Role - Janssen; Roche
 
Andreas L. Petzer
Consulting or Advisory Role - Amgen; ARIAD; Bayer; Bristol-Myers Squibb; Celgene; CTI; Gilead Sciences; Mundipharma; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - AOP Orphan Pharmaceuticals; Bristol-Myers Squibb; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Mundipharma; Novartis; Roche
 
Michael Hubalek
Honoraria - Amgen; Novartis; Roche
Consulting or Advisory Role - Celgene; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Celgene; Novartis; Roche
 
Edgar Petru
Speakers' Bureau - Acraf; Amgen; AstraZeneca; Celgene; Eisai; MSD; Novartis; Ratiopharm; Roche
 
Bernd Hartmann
No Relationships to Disclose
 
Johannes Andel
Honoraria - Amgen; Celgene; Roche
 
Marija Balic
Speakers' Bureau - AstraZeneca; Celgene; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Hanno Ulmer
No Relationships to Disclose
 
Thomas Melchardt
Travel, Accommodations, Expenses - Takeda
 
Brigitte Mlineritsch
Consulting or Advisory Role - Novartis; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Novartis; Pierre Fabre; Roche; Sanofi
 
Richard Greil
Consulting or Advisory Role - Amgen; AOP Orphan Pharmaceuticals; Baxalta; Boehringer Ingelheim; Celgene; Merck; MSD; Mundipharma; Novartis; Roche; Takeda
Speakers' Bureau - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Merck; MSD; Novartis; Roche; Takeda
Research Funding - AB Science (Inst); Abbvie (Inst); Acerta Pharma (Inst); Amgen (Inst); AOP Orphan Pharmaceuticals (Inst); Ariad (Inst); Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Morphosys (Inst); MSD (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); XBiotech (Inst)